Prediction of Oncotype DX Recurrence Score Using Clinicopathological Variables in Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer

PURPOSE: Oncotype DX (ODX) is a well-validated multigene assay that is increasingly used in Korean clinical practice. This study aimed to develop a clinicopathological prediction (CPP) model for the ODX recurrence scores (RSs). METHODS: A total of 297 patients (study group, n = 175; external validat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Min Chong, Kwon, Sun Young, Choi, Jung Eun, Kang, Su Hwan, Bae, Young Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139850/
https://www.ncbi.nlm.nih.gov/pubmed/37095618
http://dx.doi.org/10.4048/jbc.2023.26.e19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139850/
https://www.ncbi.nlm.nih.gov/pubmed/37095618
http://dx.doi.org/10.4048/jbc.2023.26.e19

Ejemplares similares